A chart purporting to show the percentage of school-aged children who are Muslim in major European capitals is based on data ...
Money & Macro on MSN
Population Decline and Growth: What It Means for the Future
A global population crisis could influence every sector of the economy. This video analyzes potential risks, shifts in labor ...
The General reports that electric vehicle adoption varies across the U.S., with states like California and Washington leading ...
November 2025 - As preparations intensify for the Second World Summit for Social Development, to be held from 4 to 6 November 2025, the Accelerating Social Progress campaign invited people from all ...
Global growth is expected to decline and downside risks to intensify as major policy shifts unfold After enduring a prolonged and unprecedented series of shocks, the global economy appeared to have ...
Maps.com on MSN
Falling Fertility Rates in Europe
While fertility rates are declining globally, they are dropping faster in some places than others. Among the continents, ...
Ensuring healthy diets for an expected global population of nearly 10 billion people in 2050, while at the same time improving the world those people live in, will require sweeping changes to farming ...
Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19 ...
Many economists and business leaders are raising alarms about falling birthrates. But advocates for lower human populations ...
I f you weighed all the world’s mammals, how much of that figure—known as biomass—would include wild animals? As of 2020, they contributed roughly 5 percent of the biomass o ...
The decline in China's population last year is likely to have exceeded the historic fall recorded in 2022, but the overall downward trend in the next three decades will be mild, a senior demographer ...
The New York-based biotech is at the centre of a bidding war between Novo Nordisk and Pfizer, both vying for access to its pipeline of experimental treatments as competition intensifies in the booming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results